Long-acting beta 2-agonists in chronic obstructive pulmonary disease.
Until recently, the use of long-acting beta 2-agonists in chronic obstructive pulmonary disease has been understated. There is now evidence that they may offer benefits beyond bronchodilation. This article reviews the management of chronic obstructive pulmonary disease and looks at the place of long-acting beta 2-agonists as a first-line treatment option.
Llewellyn-Jones
Carol
C
Department of Respiratory, West Wales General Hospital, Glangwili, Carmarthen SA31 2AF.
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000517:prevention & control; D000242:Cyclic AMP; D004417:Dyspnea / Q000209:etiology; D005541:Forced Expiratory Volume / Q000502:physiology; D005544:Forecasting; D006801:Humans; D015337:Multicenter Studies as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000382:microbiology; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D020545:Respiratory Mucosa / Q000382:microbiology
D000318:Adrenergic beta-Agonists; D000242:Cyclic AMP